Doximity annual r&d spending
2020
2021
2022
2023
2024
2025
2026
Doximity R&D Spending Growth & History (DOCS)
Doximity's r&d spending was $130.7M for fiscal 2026.
View full Doximity company overviewDoximity annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $130.7M | $37.7M | +40.48% |
| 2025 | 2025-03-31 | $93.0M | $11.1M | +13.48% |
| 2024 | 2024-03-31 | $82.0M | $1.8M | +2.24% |
| 2023 | 2023-03-31 | $80.2M | $17.8M | +28.61% |
| 2022 | 2022-03-31 | $62.4M | $18.5M | +42.11% |
| 2021 | 2021-03-31 | $43.9M | $11.4M | +35.26% |
| 2020 | 2020-03-31 | $32.4M | — | — |
Doximity quarterly r&d spending
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $38.5M | $11.7M | +43.58% |
| Q4 2026 | 2026-03-31 | $39.1M | $14.3M | +57.67% |
| Q3 2026 | 2025-12-31 | $34.6M | $12.2M | +54.30% |
| Q2 2026 | 2025-09-30 | $30.2M | $7.0M | +29.96% |
| Q1 2026 | 2025-06-30 | $26.8M | $4.2M | +18.72% |
| Q4 2025 | 2025-03-31 | $24.8M | $4.7M | +23.10% |
| Q3 2025 | 2024-12-31 | $22.4M | $2.5M | +12.41% |
| Q2 2025 | 2024-09-30 | $23.2M | $3.3M | +16.44% |
| Q1 2025 | 2024-06-30 | $22.6M | $643,000 | +2.93% |
| Q4 2024 | 2024-03-31 | $20.1M | −$1.4M | −6.47% |
| Q3 2024 | 2023-12-31 | $19.9M | −$573,000 | −2.79% |
| Q2 2024 | 2023-09-30 | $20.0M | $854,000 | +4.47% |
| Q1 2024 | 2023-06-30 | $21.9M | $2.9M | +15.29% |
| Q4 2023 | 2023-03-31 | $21.5M | $4.1M | +23.63% |
| Q3 2023 | 2022-12-31 | $20.5M | $4.3M | +26.47% |
| Q2 2023 | 2022-09-30 | $19.1M | $3.6M | +23.57% |
| Q1 2023 | 2022-06-30 | $19.0M | $5.8M | +43.66% |
| Q4 2022 | 2022-03-31 | $17.4M | $4.9M | +38.75% |
| Q3 2022 | 2021-12-31 | $16.2M | $4.8M | +42.25% |
| Q2 2022 | 2021-09-30 | $15.5M | $5.6M | +56.70% |
| Q1 2022 | 2021-06-30 | $13.2M | $3.2M | +31.84% |
| Q4 2021 | 2021-03-31 | $12.6M | — | — |
| Q3 2021 | 2020-12-31 | $11.4M | — | — |
| Q2 2021 | 2020-09-30 | $9.9M | — | — |
| Q1 2021 | 2020-06-30 | $10.0M | — | — |
Doximity r&d spending trends
Over the last five fiscal years, Doximity's r&d spending increased from $43.9M to $130.7M, a change of $86.8M. The latest reported quarter, Q1 2027, shows $38.5M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Doximity source filings ↗